Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Compare Drugs in Cytochrome P450 2C19 Inhibitors [MoA]

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now
Drug Reports Deaths Death Rate Hosp. Life-Threat. Avg Age % Female
OMEPRAZOLE 87,111 8,515 9.8% 19,847 2,963 58.7 yrs 58.9%
ESOMEPRAZOLE 75,631 7,030 9.3% 15,221 1,987 59.2 yrs 60.5%
TOPIRAMATE 28,609 3,527 12.3% 7,098 2,263 38.4 yrs 74.5%
CANNABIDIOL 18,243 1,563 8.6% 5,149 104 21.6 yrs 45.2%
FLUCONAZOLE 15,157 2,546 16.8% 5,821 1,494 51.5 yrs 55.9%
VORICONAZOLE 14,384 3,940 27.4% 5,118 1,095 52.8 yrs 38.3%
EFAVIRENZ 7,893 962 12.2% 1,528 252 40.7 yrs 37.7%
CENOBAMATE 5,643 125 2.2% 1,012 94 38.2 yrs 56.4%
ELAGOLIX 3,582 5 0.1% 299 37 34.6 yrs 99.7%
ESLICARBAZEPINE 3,127 97 3.1% 750 145 42.8 yrs 56.8%

Head-to-Head Comparisons

OMEPRAZOLE vs ESOMEPRAZOLE OMEPRAZOLE vs TOPIRAMATE OMEPRAZOLE vs CANNABIDIOL OMEPRAZOLE vs FLUCONAZOLE ESOMEPRAZOLE vs TOPIRAMATE ESOMEPRAZOLE vs CANNABIDIOL ESOMEPRAZOLE vs FLUCONAZOLE TOPIRAMATE vs CANNABIDIOL TOPIRAMATE vs FLUCONAZOLE CANNABIDIOL vs FLUCONAZOLE
← Back to Cytochrome P450 2C19 Inhibitors [MoA] Class side effects →